From: Soy isoflavones avert chronic inflammation-induced bone loss and vascular disease
Treatment | Cortical Thickness (μm) | Cortical Area (mm2) | Medullary Area (mm2) | Porosity (%) |
---|---|---|---|---|
0 IF Placebo | 0.187 ± 0.003 | 0.625 ± 0.001 | 0.010 ± 0.001 | 0.98 ± 0.28 |
0 IF LPS | 0.197 ± 0.003 | 0.646 ± 0.010 | 0.010 ± 0.002 | 0.84 ± 0.20 |
126 IF Placebo | 0.193 ± 0.002 | 0.628 ± 0.014 | 0.009 ± 0.001 | 1.07 ± 0.22 |
126 IF LPS | 0.191 ± 0.003 | 0.625 ± 0.008 | 0.012 ± 0.002 | 1.08 ± 0.31 |
504 IF Placebo | 0.194 ± 0.005 | 0.625 ± 0.014 | 0.010 ± 0.001 | 0.99 ± 0.24 |
504 IF LPS | 0.198 ± 0.001 | 0.652 ± 0.011 | 0.009 ± 0.001 | 0.86 ± 0.22 |
P value | Â | Â | Â | Â |
LPS | 0.1340 | 0.1086 | 0.4386 | 0.6895 |
IF | 0.4189 | 0.5571 | 0.5553 | 0.7637 |
LPS*IF | 0.1293 | 0.3899 | 0.1988 | 0.9444 |